Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma - Xu-Monette, Zijun Y.; Li, Ling; Byrd, John C.; Jabbar, Kausar J.; Manyam, Ganiraju C.; Maria de Winde, Charlotte; van den Brand, Michiel; Tzankov, Alexandar; Visco, Carlo; Wang, Jing; Dybkaer, Karen; Chiu, April; et al. (Blood, 2016)
Keywords: Antigens, CD20 - genetics; Antigens, CD20 - metabolism; Antigens, Neoplasm - genetics; Antigens, Neoplasm - metabolism; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; B-Lymphocytes - metabolism; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Germinal Center - pathology; Humans; Lymphoid Neoplasia; Lymphoma, Large B-Cell, Diffuse - drug therapy; Lymphoma, Large B-Cell, Diffuse - genetics; Lymphoma, Large B-Cell, Diffuse - metabolism; Lymphoma, Large B-Cell, Diffuse - pathology; Male; Middle Aged; Models, Biological; Multivariate Analysis; Mutation - genetics; NF-kappa B - metabolism; Prognosis; Programmed Cell Death 1 Receptor - metabolism; Protein Transport; Proto-Oncogene Proteins c-myc - metabolism; Risk Factors; RNA, Messenger - genetics; RNA, Messenger - metabolism; Survival Analysis; Tetraspanins - genetics; Tetraspanins - metabolism; Treatment Outcome; Tumor Suppressor Protein p53 - genetics